Selected research
Industry Research
Biodegradable Type Embolic Microspheres Industry Research Report 2026
Market perspective
The global Biodegradable Type Embolic Microspheres market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Biodegradable Type Embolic Microspheres is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Biodegradable Type Embolic Microspheres is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Biodegradable Type Embolic Microspheres is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Biodegradable Type Embolic Microspheres include , among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Biodegradable Type Embolic Microspheres market in revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Biodegradable Type Embolic Microspheres.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Biodegradable Type Embolic Microspheres Market by Company
ABK Biomedical
Angio Dynamics
Biocompatibles
Biosphere Medical
BTG Corporate
CeloNova BioSciences
Merit Medical Systems
Mermaid Medical
Next Biomedical
Occlugel
Promedics AG
Teleflex
Tepha
Terumo Corporation
Varian
Nippon Kayaku
Jiangsu Hengrui Medicine
Biodegradable Type Embolic Microspheres Segment by Type
Visualization Type
Radioactive Type
Environmentally Responsive Type
Other
Biodegradable Type Embolic Microspheres Segment by Application
Hospitals And Clinics
Research Institution
Biodegradable Type Embolic Microspheres Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biodegradable Type Embolic Microspheres market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biodegradable Type Embolic Microspheres and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biodegradable Type Embolic Microspheres.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Biodegradable Type Embolic Microspheres manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Biodegradable Type Embolic Microspheres by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Biodegradable Type Embolic Microspheres in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Visualization Type
- Radioactive Type
- Environmentally Responsive Type
- Other
Applications
- Hospitals And Clinics
- Research Institution
Companies covered
- ABK Biomedical
- Angio Dynamics
- Biocompatibles
- Biosphere Medical
- BTG Corporate
- CeloNova BioSciences
- Merit Medical Systems
- Mermaid Medical
- Next Biomedical
- Occlugel
- Promedics AG
- Teleflex
- Tepha
- Terumo Corporation
- Varian
- Nippon Kayaku
- Jiangsu Hengrui Medicine
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Biodegradable Type Embolic Microspheres by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Visualization Type
- 2.2.3 Radioactive Type
- 2.2.4 Environmentally Responsive Type
- 2.2.5 Other
- 2.3 Biodegradable Type Embolic Microspheres by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Hospitals And Clinics
- 2.3.3 Research Institution
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Biodegradable Type Embolic Microspheres Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Biodegradable Type Embolic Microspheres Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Biodegradable Type Embolic Microspheres Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Biodegradable Type Embolic Microspheres Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Biodegradable Type Embolic Microspheres Production by Manufacturers (2021-2026)
- 3.2 Global Biodegradable Type Embolic Microspheres Production Value by Manufacturers (2021-2026)
- 3.3 Global Biodegradable Type Embolic Microspheres Average Price by Manufacturers (2021-2026)
- 3.4 Global Biodegradable Type Embolic Microspheres Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Biodegradable Type Embolic Microspheres Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Biodegradable Type Embolic Microspheres Manufacturers, Product Type & Application
- 3.7 Global Biodegradable Type Embolic Microspheres Manufacturers Established Date
- 3.8 Global Biodegradable Type Embolic Microspheres Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 ABK Biomedical
- 4.1.1 ABK Biomedical Biodegradable Type Embolic Microspheres Company Information
- 4.1.2 ABK Biomedical Biodegradable Type Embolic Microspheres Business Overview
- 4.1.3 ABK Biomedical Biodegradable Type Embolic Microspheres Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 ABK Biomedical Product Portfolio
- 4.1.5 ABK Biomedical Recent Developments
- 4.2 Angio Dynamics
- 4.2.1 Angio Dynamics Biodegradable Type Embolic Microspheres Company Information
- 4.2.2 Angio Dynamics Biodegradable Type Embolic Microspheres Business Overview
- 4.2.3 Angio Dynamics Biodegradable Type Embolic Microspheres Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 Angio Dynamics Product Portfolio
- 4.2.5 Angio Dynamics Recent Developments
- 4.3 Biocompatibles
- 4.3.1 Biocompatibles Biodegradable Type Embolic Microspheres Company Information
- 4.3.2 Biocompatibles Biodegradable Type Embolic Microspheres Business Overview
- 4.3.3 Biocompatibles Biodegradable Type Embolic Microspheres Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 Biocompatibles Product Portfolio
- 4.3.5 Biocompatibles Recent Developments
- 4.4 Biosphere Medical
- 4.4.1 Biosphere Medical Biodegradable Type Embolic Microspheres Company Information
- 4.4.2 Biosphere Medical Biodegradable Type Embolic Microspheres Business Overview
- 4.4.3 Biosphere Medical Biodegradable Type Embolic Microspheres Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 Biosphere Medical Product Portfolio
- 4.4.5 Biosphere Medical Recent Developments
- 4.5 BTG Corporate
- 4.5.1 BTG Corporate Biodegradable Type Embolic Microspheres Company Information
- 4.5.2 BTG Corporate Biodegradable Type Embolic Microspheres Business Overview
- 4.5.3 BTG Corporate Biodegradable Type Embolic Microspheres Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 BTG Corporate Product Portfolio
- 4.5.5 BTG Corporate Recent Developments
- 4.6 CeloNova BioSciences
- 4.6.1 CeloNova BioSciences Biodegradable Type Embolic Microspheres Company Information
- 4.6.2 CeloNova BioSciences Biodegradable Type Embolic Microspheres Business Overview
- 4.6.3 CeloNova BioSciences Biodegradable Type Embolic Microspheres Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 CeloNova BioSciences Product Portfolio
- 4.6.5 CeloNova BioSciences Recent Developments
- 4.7 Merit Medical Systems
- 4.7.1 Merit Medical Systems Biodegradable Type Embolic Microspheres Company Information
- 4.7.2 Merit Medical Systems Biodegradable Type Embolic Microspheres Business Overview
- 4.7.3 Merit Medical Systems Biodegradable Type Embolic Microspheres Production Capacity, Value and Gross Margin (2021-2026)
- 4.7.4 Merit Medical Systems Product Portfolio
- 4.7.5 Merit Medical Systems Recent Developments
- 4.8 Mermaid Medical
- 4.8.1 Mermaid Medical Biodegradable Type Embolic Microspheres Company Information
- 4.8.2 Mermaid Medical Biodegradable Type Embolic Microspheres Business Overview
- 4.8.3 Mermaid Medical Biodegradable Type Embolic Microspheres Production Capacity, Value and Gross Margin (2021-2026)
- 4.8.4 Mermaid Medical Product Portfolio
- 4.8.5 Mermaid Medical Recent Developments
- 4.9 Next Biomedical
- 4.9.1 Next Biomedical Biodegradable Type Embolic Microspheres Company Information
- 4.9.2 Next Biomedical Biodegradable Type Embolic Microspheres Business Overview
- 4.9.3 Next Biomedical Biodegradable Type Embolic Microspheres Production Capacity, Value and Gross Margin (2021-2026)
- 4.9.4 Next Biomedical Product Portfolio
- 4.9.5 Next Biomedical Recent Developments
- 4.10 Occlugel
- 4.10.1 Occlugel Biodegradable Type Embolic Microspheres Company Information
- 4.10.2 Occlugel Biodegradable Type Embolic Microspheres Business Overview
- 4.10.3 Occlugel Biodegradable Type Embolic Microspheres Production Capacity, Value and Gross Margin (2021-2026)
- 4.10.4 Occlugel Product Portfolio
- 4.10.5 Occlugel Recent Developments
- 4.11 Promedics AG
- 4.11.1 Promedics AG Biodegradable Type Embolic Microspheres Company Information
- 4.11.2 Promedics AG Biodegradable Type Embolic Microspheres Business Overview
- 4.11.3 Promedics AG Biodegradable Type Embolic Microspheres Production Capacity, Value and Gross Margin (2021-2026)
- 4.11.4 Promedics AG Product Portfolio
- 4.11.5 Promedics AG Recent Developments
- 4.12 Teleflex
- 4.12.1 Teleflex Biodegradable Type Embolic Microspheres Company Information
- 4.12.2 Teleflex Biodegradable Type Embolic Microspheres Business Overview
- 4.12.3 Teleflex Biodegradable Type Embolic Microspheres Production Capacity, Value and Gross Margin (2021-2026)
- 4.12.4 Teleflex Product Portfolio
- 4.12.5 Teleflex Recent Developments
- 4.13 Tepha
- 4.13.1 Tepha Biodegradable Type Embolic Microspheres Company Information
- 4.13.2 Tepha Biodegradable Type Embolic Microspheres Business Overview
- 4.13.3 Tepha Biodegradable Type Embolic Microspheres Production Capacity, Value and Gross Margin (2021-2026)
- 4.13.4 Tepha Product Portfolio
- 4.13.5 Tepha Recent Developments
- 4.14 Terumo Corporation
- 4.14.1 Terumo Corporation Biodegradable Type Embolic Microspheres Company Information
- 4.14.2 Terumo Corporation Biodegradable Type Embolic Microspheres Business Overview
- 4.14.3 Terumo Corporation Biodegradable Type Embolic Microspheres Production Capacity, Value and Gross Margin (2021-2026)
- 4.14.4 Terumo Corporation Product Portfolio
- 4.14.5 Terumo Corporation Recent Developments
- 4.15 Varian
- 4.15.1 Varian Biodegradable Type Embolic Microspheres Company Information
- 4.15.2 Varian Biodegradable Type Embolic Microspheres Business Overview
- 4.15.3 Varian Biodegradable Type Embolic Microspheres Production Capacity, Value and Gross Margin (2021-2026)
- 4.15.4 Varian Product Portfolio
- 4.15.5 Varian Recent Developments
- 4.16 Nippon Kayaku
- 4.16.1 Nippon Kayaku Biodegradable Type Embolic Microspheres Company Information
- 4.16.2 Nippon Kayaku Biodegradable Type Embolic Microspheres Business Overview
- 4.16.3 Nippon Kayaku Biodegradable Type Embolic Microspheres Production Capacity, Value and Gross Margin (2021-2026)
- 4.16.4 Nippon Kayaku Product Portfolio
- 4.16.5 Nippon Kayaku Recent Developments
- 4.17 Jiangsu Hengrui Medicine
- 4.17.1 Jiangsu Hengrui Medicine Biodegradable Type Embolic Microspheres Company Information
- 4.17.2 Jiangsu Hengrui Medicine Biodegradable Type Embolic Microspheres Business Overview
- 4.17.3 Jiangsu Hengrui Medicine Biodegradable Type Embolic Microspheres Production Capacity, Value and Gross Margin (2021-2026)
- 4.17.4 Jiangsu Hengrui Medicine Product Portfolio
- 4.17.5 Jiangsu Hengrui Medicine Recent Developments
5 Global Biodegradable Type Embolic Microspheres Production by Region
- 5.1 Global Biodegradable Type Embolic Microspheres Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Biodegradable Type Embolic Microspheres Production by Region: 2021-2032
- 5.2.1 Global Biodegradable Type Embolic Microspheres Production by Region: 2021-2026
- 5.2.2 Global Biodegradable Type Embolic Microspheres Production Forecast by Region (2027-2032)
- 5.3 Global Biodegradable Type Embolic Microspheres Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Biodegradable Type Embolic Microspheres Production Value by Region: 2021-2032
- 5.4.1 Global Biodegradable Type Embolic Microspheres Production Value by Region: 2021-2026
- 5.4.2 Global Biodegradable Type Embolic Microspheres Production Value Forecast by Region (2027-2032)
- 5.5 Global Biodegradable Type Embolic Microspheres Market Price Analysis by Region (2021-2026)
- 5.6 Global Biodegradable Type Embolic Microspheres Production and Value, YOY Growth
- 5.6.1 North America Biodegradable Type Embolic Microspheres Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Biodegradable Type Embolic Microspheres Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Biodegradable Type Embolic Microspheres Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Biodegradable Type Embolic Microspheres Production Value Estimates and Forecasts (2021-2032)
6 Global Biodegradable Type Embolic Microspheres Consumption by Region
- 6.1 Global Biodegradable Type Embolic Microspheres Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Biodegradable Type Embolic Microspheres Consumption by Region (2021-2032)
- 6.2.1 Global Biodegradable Type Embolic Microspheres Consumption by Region: 2021-2026
- 6.2.2 Global Biodegradable Type Embolic Microspheres Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Biodegradable Type Embolic Microspheres Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Biodegradable Type Embolic Microspheres Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Biodegradable Type Embolic Microspheres Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Biodegradable Type Embolic Microspheres Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Biodegradable Type Embolic Microspheres Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Biodegradable Type Embolic Microspheres Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Biodegradable Type Embolic Microspheres Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Biodegradable Type Embolic Microspheres Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Biodegradable Type Embolic Microspheres Production by Type (2021-2032)
- 7.1.1 Global Biodegradable Type Embolic Microspheres Production by Type (2021-2032) & (Tons)
- 7.1.2 Global Biodegradable Type Embolic Microspheres Production Market Share by Type (2021-2032)
- 7.2 Global Biodegradable Type Embolic Microspheres Production Value by Type (2021-2032)
- 7.2.1 Global Biodegradable Type Embolic Microspheres Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Biodegradable Type Embolic Microspheres Production Value Market Share by Type (2021-2032)
- 7.3 Global Biodegradable Type Embolic Microspheres Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Biodegradable Type Embolic Microspheres Production by Application (2021-2032)
- 8.1.1 Global Biodegradable Type Embolic Microspheres Production by Application (2021-2032) & (Tons)
- 8.1.2 Global Biodegradable Type Embolic Microspheres Production Market Share by Application (2021-2032)
- 8.2 Global Biodegradable Type Embolic Microspheres Production Value by Application (2021-2032)
- 8.2.1 Global Biodegradable Type Embolic Microspheres Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Biodegradable Type Embolic Microspheres Production Value Market Share by Application (2021-2032)
- 8.3 Global Biodegradable Type Embolic Microspheres Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Biodegradable Type Embolic Microspheres Value Chain Analysis
- 9.1.1 Biodegradable Type Embolic Microspheres Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Biodegradable Type Embolic Microspheres Production Mode & Process
- 9.2 Biodegradable Type Embolic Microspheres Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Biodegradable Type Embolic Microspheres Distributors
- 9.2.3 Biodegradable Type Embolic Microspheres Customers
10 Global Biodegradable Type Embolic Microspheres Analyzing Market Dynamics
- 10.1 Biodegradable Type Embolic Microspheres Industry Trends
- 10.2 Biodegradable Type Embolic Microspheres Industry Drivers
- 10.3 Biodegradable Type Embolic Microspheres Industry Opportunities and Challenges
- 10.4 Biodegradable Type Embolic Microspheres Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst